Studies have shown that COVID-19 patients with severe respiratory symptoms have significantly lower levels of HGF in their blood and that treatment with HGF can reduce lung inflammation and prevent the progression of COVID-19-related lung injury (Xiao et al., 2020). Here, HGF is linked to COVID-19.